Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 2,051 | 2,458 | 2,273 | 2,906 | 2,366 |
| Operating Income | -2,051 | -2,458 | -2,273 | -2,906 | -2,366 |
| Other Income | -82 | -164 | 414 | 18 | 34 |
| Pre-tax Income | -2,133 | -2,622 | -1,859 | -2,888 | -2,331 |
| Net Income Continuous | -2,133 | -2,622 | -1,859 | -2,888 | -2,331 |
| Net Income | $-2,133 | $-2,622 | $-1,859 | $-2,888 | $-2,331 |
| EPS Basic Total Ops | -0.06 | -0.09 | -0.06 | -0.10 | -0.08 |
| EPS Basic Continuous Ops | -0.06 | -0.09 | -0.06 | -0.10 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.09 | -0.06 | -0.10 | -0.08 |
| EPS Diluted Continuous Ops | -0.06 | -0.09 | -0.06 | -0.10 | -0.08 |
| EBITDA(a) | $-2,041 | $-2,448 | $-2,263 | $-2,896 | $-2,356 |